• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Elevated soluble CD 27 levels (TNF-receptor) may predict survival in diffuse large B-cell lymphoma--revisiting "the super- family " saga.

作者信息

Tadmor Tamar, Polliack Aaron

机构信息

Hematology Unit, Bnai-Zion Medical Center, Haifa, Israel.

出版信息

Leuk Lymphoma. 2012 Aug;53(8):1439-40. doi: 10.3109/10428194.2012.666546. Epub 2012 Mar 13.

DOI:10.3109/10428194.2012.666546
PMID:22335528
Abstract
摘要

相似文献

1
Elevated soluble CD 27 levels (TNF-receptor) may predict survival in diffuse large B-cell lymphoma--revisiting "the super- family " saga.
Leuk Lymphoma. 2012 Aug;53(8):1439-40. doi: 10.3109/10428194.2012.666546. Epub 2012 Mar 13.
2
Serum soluble CD27 level is associated with outcome in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone.血清可溶性 CD27 水平与接受利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松龙治疗的弥漫性大 B 细胞淋巴瘤患者的预后相关。
Leuk Lymphoma. 2012 Aug;53(8):1494-500. doi: 10.3109/10428194.2012.660627. Epub 2012 Mar 1.
3
High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?高危弥漫性大B细胞淋巴瘤：我们能否比利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松做得更好？
Leuk Lymphoma. 2013 Dec;54(12):2575-6. doi: 10.3109/10428194.2013.796059. Epub 2013 May 21.
4
Serum soluble tumor necrosis factor receptor 1 level is associated with the outcome of diffuse large B-cell lymphoma patients treated with the CHOP or R-CHOP regimen.血清可溶性肿瘤坏死因子受体1水平与接受CHOP或R-CHOP方案治疗的弥漫性大B细胞淋巴瘤患者的预后相关。
J Clin Exp Hematop. 2014;54(2):117-27. doi: 10.3960/jslrt.54.117.
5
Targeting drug resistance to close the gap in diffuse large B-cell lymphoma.
Leuk Lymphoma. 2014 Sep;55(9):1966-7. doi: 10.3109/10428194.2014.898762. Epub 2014 Mar 25.
6
Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen.可溶性肿瘤坏死因子受体 2 血清水平与接受 R-CHOP 方案治疗的弥漫性大 B 细胞淋巴瘤患者的预后相关。
Eur J Haematol. 2013 Oct;91(4):322-31. doi: 10.1111/ejh.12139. Epub 2013 Jul 7.
7
R2-CHOP vs R-CHOP for diffuse large B-cell lymphoma.R2-CHOP方案与R-CHOP方案治疗弥漫性大B细胞淋巴瘤的比较
Clin Adv Hematol Oncol. 2014 Sep;12(9):608-10.
8
Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy.利妥昔单抗与苯达莫司汀用于不符合环磷酰胺、多柔比星、长春新碱和泼尼松样化疗条件的CD20+弥漫性大B细胞淋巴瘤患者。
Leuk Lymphoma. 2012 Nov;53(11):2290-2. doi: 10.3109/10428194.2012.682311. Epub 2012 May 22.
9
Indoleamine 2,3-dioxygenase expression and serum kynurenine concentrations in patients with diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤患者中吲哚胺2,3-双加氧酶的表达及血清犬尿氨酸浓度
Leuk Lymphoma. 2012 Jun;53(6):1143-5. doi: 10.3109/10428194.2011.643472. Epub 2012 Jan 11.
10
There is life in the old dog yet: thymidine kinase as predictive marker in diffuse large B-cell lymphoma.
Leuk Lymphoma. 2013 Nov;54(11):2343-4. doi: 10.3109/10428194.2013.807513. Epub 2013 Jul 16.